Jonathan S. Leff
Board Member
ARS Pharmaceuticals, Inc. (SPRY)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jonathan S. Leff
Jonathan S. Leff is recorded as Board Member at ARS Pharmaceuticals, Inc. (SPRY). ARS Pharmaceuticals, Inc. reported in an 8-K filed November 8, 2022 that Jonathan S. Leff was appointed Class III Director, effective November 8, 2022.
“At the effective time of the Merger, the Company's board of directors (and its committees) and executive officers were reconstituted to include the following directors and executive officers”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-11-08–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ARS Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Donn Casale CEO, Board Member
- Rich Lowenthal CEO
- Richard Lowenthal CEO
- Pratik Shah Chairman
- Kathleen Scott CFO
- Russ Hawkinson CFO
- Brian Dorsey COO
- Brenton L. Saunders Board Member
- Laura Shawver Board Member
- Michael Kelly Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.